412 related articles for article (PubMed ID: 15033248)
21. Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis.
Gritti G; Cortelezzi A; Bucciarelli P; Rezzonico F; Lonati S; La Marca S; Silvestris I; Federici AB
Am J Hematol; 2011 Aug; 86(8):650-6. PubMed ID: 21630316
[TBL] [Abstract][Full Text] [Related]
22. Dysfunctional vasa vasorum in diabetic peripheral artery obstructive disease with critical lower limb ischaemia.
Orrico C; Pasquinelli G; Foroni L; Muscarà D; Tazzari PL; Ricci F; Buzzi M; Baldi E; Muccini N; Gargiulo M; Stella A
Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):365-74. PubMed ID: 20570185
[TBL] [Abstract][Full Text] [Related]
23. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?
Małyszko J; Małyszko JS; Myśliwiec M
Thromb Res; 2005; 115(1-2):19-24. PubMed ID: 15567448
[TBL] [Abstract][Full Text] [Related]
24. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
25. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
26. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
[TBL] [Abstract][Full Text] [Related]
27. Increased circulating endothelial cells in acute heart failure: comparison with von Willebrand factor and soluble E-selectin.
Chong AY; Lip GY; Freestone B; Blann AD
Eur J Heart Fail; 2006 Mar; 8(2):167-72. PubMed ID: 16185922
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis?
Freestone B; Chong AY; Lim HS; Blann A; Lip GY
Ann Med; 2005; 37(5):365-72. PubMed ID: 16179272
[TBL] [Abstract][Full Text] [Related]
29. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis.
Fürstenberger G; von Moos R; Senn HJ; Boneberg EM
Br J Cancer; 2005 Oct; 93(7):793-8. PubMed ID: 16160694
[TBL] [Abstract][Full Text] [Related]
30. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
31. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
[TBL] [Abstract][Full Text] [Related]
32. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
33. Circulating endothelial cells in cardiovascular disease.
Boos CJ; Lip GY; Blann AD
J Am Coll Cardiol; 2006 Oct; 48(8):1538-47. PubMed ID: 17045885
[TBL] [Abstract][Full Text] [Related]
34. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
36. Circulating endothelial cells in cancer patients do not express tissue factor.
Beerepoot LV; Mehra N; Linschoten F; Jorna AS; Lisman T; Verheul HM; Voest EE
Cancer Lett; 2004 Sep; 213(2):241-8. PubMed ID: 15327840
[TBL] [Abstract][Full Text] [Related]
37. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes.
Boos CJ; Soor SK; Kang D; Lip GY
Eur Heart J; 2007 May; 28(9):1092-101. PubMed ID: 17449878
[TBL] [Abstract][Full Text] [Related]
38. The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes.
Emekli-Alturfan E; Basar I; Alturfan AA; Ayan F; Koldas L; Balci H; Emekli N
Pathophysiol Haemost Thromb; 2007; 36(6):290-7. PubMed ID: 20224254
[TBL] [Abstract][Full Text] [Related]
39. Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy.
Erdbruegger U; Woywodt A; Kirsch T; Haller H; Haubitz M
Am J Kidney Dis; 2006 Oct; 48(4):564-70. PubMed ID: 16997052
[TBL] [Abstract][Full Text] [Related]
40. [Changes of plasma von Willebrond factor and soluble E-selectin levels in patients with coronary artery disease].
Lin GQ; Jiang HH; Li YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):399-402. PubMed ID: 16190382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
